ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.14M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$146.03
Trade value
$1.39M
% of position
Common Stock
Shares
−399.00
Price / share
$537.40
Trade value
$214.42K
% of position
Common Stock
Shares
−401.00
Price / share
$538.43
Trade value
$215.91K
% of position
Common Stock
Shares
−535.00
Price / share
$539.24
Trade value
$288.49K
% of position
Common Stock
Shares
−3.15K
Price / share
$540.46
Trade value
$1.70M
% of position
Common Stock
Shares
−1.67K
Price / share
$541.23
Trade value
$904.39K
% of position
Common Stock
Shares
−1.80K
Price / share
$542.40
Trade value
$974.69K
% of position
Common Stock
Shares
−240.00
Price / share
$543.03
Trade value
$130.33K
% of position
Common Stock
Shares
−560.00
Price / share
$544.45
Trade value
$304.89K
% of position
Common Stock
Shares
−743.00
Price / share
$545.71
Trade value
$405.46K
% of position
Net shares
+0.00
Net value
-$3.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +9.50K | $146.03 | $1.39M | 23.4% | 40.51K | 50.01K |
| Common Stock Direct | 6/12/2026 | S · Sale | −399.00 | $537.40 | $214.42K | 0.8% | 50.01K | 49.61K |
| Common Stock Direct | 6/12/2026 | S · Sale | −401.00 | $538.43 | $215.91K | 0.8% | 49.61K | 49.21K |
| Common Stock Direct | 6/12/2026 | S · Sale | −535.00 | $539.24 | $288.49K | 1.1% | 49.21K | 48.68K |
| Common Stock Direct | 6/12/2026 | S · Sale | −3.15K | $540.46 | $1.70M | 6.5% | 48.68K | 45.52K |
| Common Stock Direct | 6/12/2026 | S · Sale | −1.67K | $541.23 | $904.39K | 3.7% | 45.52K | 43.85K |
| Common Stock Direct | 6/12/2026 | S · Sale | −1.80K | $542.40 | $974.69K | 4.1% | 43.85K | 42.06K |
| Common Stock Direct | 6/12/2026 | S · Sale | −240.00 | $543.03 | $130.33K | 0.6% | 42.06K | 41.82K |
| Common Stock Direct | 6/12/2026 | S · Sale | −560.00 | $544.45 | $304.89K | 1.3% | 41.82K | 41.26K |
| Common Stock Direct | 6/12/2026 | S · Sale | −743.00 | $545.71 | $405.46K | 1.8% | 41.26K | 40.51K |
| Total | +0.00 | -$3.76M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
146.03
Held after
40.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock9.50K shares | 6/12/2026 | M · Option Exercise | −9.50K | 146.03 | — | 40.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 45.60K | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 324.44K | Indirect |
| Common Stock | 166.00 | Indirect |
| Total | 628.22K | 628.22K indirect |